Consistent with this idea, expression of the KIF17 NR box in breast cancer cells inhibited the expression of a subset of ERR1 gene targets, suggesting that KIF17 is a selective, competitive inhibitor of ERR1 cofactor binding in the nuclear compartment. The gene discussed is ESRRA; the disease is breast carcinoma.